Log In or Register to Join The Conversation!

This topic has 2 replies, 2 voices, and was last updated 8 months, 3 weeks ago by Alyssa Silva.

  • Author
    Posts
    • #22624
      Alyssa Silva
      Keymaster

      With the first-ever oral drug of its kind, risdiplam is sure to open new doors for the SMA community. This especially holds true for those who have spinal fusions and are unable to get Spinraza administered as a result.

      Would you like to know more about risdiplam? If so, please send us your questions so that we can try to help you.

    • #22682
      Tracy Odell
      Participant

      What are the benefits expected for older adults with SMA 2 (50+ years)?

      Do you have to take it every day for the rest of your life?

      What is the expected cost?

    • #22699
      Alyssa Silva
      Keymaster

      All excellent questions, Tracy! I’m curious to know these answers, too.

      With the drug currently under review, the FDA limits the amount of information the pharmaceutical company is allowed to release. Right now, the only concrete information we know is that Roche/Genentech has received priority review status, and this priority review status gives a good indication of the success of the clinical trials. But until the FDA actually grants Roche/Genentech approval for risdiplam, it’s probably more speculation than fact.

      When more information becomes available, we will be sure to inform our forum members as soon as possible!

Viewing 2 reply threads
  • You must be logged in to reply to this topic.

©2020 KLEO Template a premium and multipurpose theme from Seventh Queen

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending
or

Log in with your credentials

or    

Forgot your details?

or

Create Account

Copyright © 2017-2020 All rights reserved.